Summary
Codeine phosphate effectively reduces ileostomy output weight and water/electrolyte loss, improving ileostomy function. Lomotil showed a lesser effect, while Isogel worsened fluid and electrolyte depletion.
Area of Science:
- Gastroenterology
- Clinical Pharmacology
- Surgical Patient Management
Background:
- Ileostomy output management is crucial for patient well-being.
- Fluid and electrolyte balance is a significant concern for ileostomy patients.
Purpose of the Study:
- To evaluate the effects of codeine phosphate, Lomotil, and Isogel on ileostomy function.
- To determine the impact of these agents on ileostomy output volume, composition, and transit time.
Main Methods:
- A randomized, controlled trial involving 20 ileostomy subjects living at home.
- Subjects underwent two three-day periods, one on treatment and one off.
- Measurements included ileostomy output weight, water, sodium, potassium, and fecal solids.
Main Results:
- Codeine phosphate significantly reduced ileostomy output weight and water/electrolyte losses (p < 0.05).
- Lomotil demonstrated a trend towards reduced output but only significantly decreased sodium and potassium losses (p < 0.05).
- Isogel significantly increased ileostomy output of water, electrolytes, and solids (p < 0.01), potentially worsening dehydration.
Conclusions:
- Codeine phosphate offers a beneficial effect on ileostomy function by reducing fluid and electrolyte losses.
- Lomotil has a similar but less potent effect at the tested dosage.
- Isogel exacerbates fluid and electrolyte depletion in ileostomy patients and should be avoided in cases of excessive output.
Related Concept Videos
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
907
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
907
Drugs Affecting GI Tract Motility: Other Laxatives
1.6K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.6K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
854
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
854
Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Drugs for Treatment of Constipation-Predominant IBS
1.4K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K


